KURA
Income statement / Annual
Last year (2025), Kura Oncology Inc's total revenue was $67.48 M,
an increase of 25.24% from the previous year.
In 2025, Kura Oncology Inc's net income was -$278.67 M.
See Kura Oncology Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$67.48 M |
$53.88 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$57.00 K
|
$0.00
|
$849.00 K
|
$0.00
|
$0.00
|
$194.00 K
|
$0.00
|
$10.00 K
|
$30.00 K
|
$31.00 K
|
| Gross Profit |
$67.43 M
|
$53.88 M
|
-$849.00 K
|
$0.00
|
$0.00
|
-$194.00 K
|
$0.00
|
-$10.00 K
|
-$30.00 K
|
-$31.00 K
|
| Gross Profit Ratio |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$251.07 M
|
$169.97 M
|
$115.24 M
|
$92.81 M
|
$84.72 M
|
$60.40 M
|
$47.83 M
|
$46.79 M
|
$26.43 M
|
$20.40 M
|
| General & Administrative Expenses |
$119.98 M
|
$77.11 M
|
$50.57 M
|
$47.05 M
|
$46.54 M
|
$31.31 M
|
$19.65 M
|
$16.10 M
|
$9.65 M
|
$7.96 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$119.98 M
|
$77.11 M
|
$50.57 M
|
$47.05 M
|
$46.54 M
|
$31.31 M
|
$19.65 M
|
$16.10 M
|
$9.65 M
|
$7.96 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$849.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$371.06 M
|
$247.08 M
|
$164.96 M
|
$139.87 M
|
$131.26 M
|
$91.71 M
|
$67.48 M
|
$62.88 M
|
$36.08 M
|
$28.37 M
|
| Cost And Expenses |
$371.11 M
|
$247.08 M
|
$165.80 M
|
$139.87 M
|
$131.26 M
|
$91.90 M
|
$67.48 M
|
$62.88 M
|
$36.08 M
|
$28.37 M
|
| Interest Income |
$26.77 M
|
$22.85 M
|
$14.72 M
|
$4.25 M
|
$1.21 M
|
$2.80 M
|
$4.67 M
|
$3.17 M
|
$751.00 K
|
$499.00 K
|
| Interest Expense |
$1.51 M
|
$1.62 M
|
$1.55 M
|
$229.00 K
|
$414.00 K
|
$578.00 K
|
$580.00 K
|
$970.00 K
|
$888.00 K
|
$577.00 K
|
| Depreciation & Amortization |
$1.03 M
|
$848.00 K
|
$849.00 K
|
$759.00 K
|
$558.00 K
|
$194.00 K
|
$10.00 K
|
$10.00 K
|
$30.00 K
|
$31.00 K
|
| EBITDA |
-$275.83 M |
-$169.50 M |
-$150.23 M |
-$134.85 M |
-$129.49 M |
-$88.85 M |
-$67.47 M |
-$62.87 M |
-$36.05 M |
-$28.34 M |
| EBITDA Ratio |
-4.09
|
-3.15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-4.5
|
-3.59
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$25.26 M
|
$21.23 M
|
$13.17 M
|
$4.03 M
|
$792.00 K
|
$2.27 M
|
$4.44 M
|
$2.64 M
|
$943.00 K
|
$807.00 K
|
| Income Before Tax |
-$278.37 M
|
-$171.97 M
|
-$152.63 M
|
-$135.84 M
|
-$130.47 M
|
-$89.63 M
|
-$63.14 M
|
-$60.45 M
|
-$35.43 M
|
-$27.56 M
|
| Income Before Tax Ratio |
-4.13
|
-3.19
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$297.00 K
|
$2.02 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$30.00 K
|
-$31.00 K
|
| Net Income |
-$278.67 M
|
-$173.98 M
|
-$152.63 M
|
-$135.84 M
|
-$130.47 M
|
-$89.63 M
|
-$63.14 M
|
-$60.45 M
|
-$35.43 M
|
-$27.56 M
|
| Net Income Ratio |
-4.13
|
-3.23
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-3.18 |
-2.02 |
-2.08 |
-2.03 |
-1.97 |
-1.69 |
-1.51 |
-1.72 |
-1.52 |
-1.47 |
| EPS Diluted |
-3.18 |
-2.02 |
-2.08 |
-2.03 |
-1.97 |
-1.69 |
-1.51 |
-1.72 |
-1.52 |
-1.47 |
| Weighted Average Shares Out |
$87.68 M
|
$86.16 M
|
$73.23 M
|
$66.99 M
|
$66.35 M
|
$53.08 M
|
$41.95 M
|
$35.19 M
|
$23.24 M
|
$18.70 M
|
| Weighted Average Shares Out Diluted |
$87.68 M
|
$86.16 M
|
$73.23 M
|
$66.99 M
|
$66.35 M
|
$53.08 M
|
$41.95 M
|
$35.19 M
|
$23.24 M
|
$18.70 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
